912
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Stereotactic radiofrequency thermocoagulation application in the anterior limbs of patients’ internal capsules in treating intractable tic disorders

, , , &
Pages 332-337 | Received 05 Dec 2019, Accepted 20 Mar 2020, Published online: 07 Apr 2020

References

  • Eapen V, Cavanna AE, Robertson MM. Comorbidities, social impact, and quality of life in tourette syndrome. Front Psychiatry. 2016;7:97.
  • Jankovic J. Tourette’s syndrome. N Engl J Med. 2001;345(16):1184–1192.
  • Casagrande SCB, Cury RG, Alho EJL, et al. Deep brain stimulation in tourette’s syndrome: evidence to date. Neuropsychiatr Dis Treat. 2019;15:1061–1075.
  • Peterson BS, Leckman JF. The temporal dynamics of tics in gilles de la tourette syndrome. Biol Psychiatry. 1998;44(12):1337–1348.
  • Wang S, Qi F, Li J, et al. Effects of chinese herbal medicine ningdong granule on regulating dopamine (da)/serotonin (5-th) and gamma-amino butyric acid (gaba) in patients with tourette syndrome. Biosci Trends. 2012;6(4):212–218.
  • Leckman JF. Tourette’s syndrome. Lancet. 2002;360(9345):1577–1586.
  • Eddy CM, Rickards HE, Cavanna AE. Treatment strategies for tics in tourette syndrome. Ther Adv Neurol Disord. 2011;4(1):25–45.
  • Freeman RD, Fast DK, Burd L, et al. An international perspective on tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42(7):436–447.
  • Malaty IA, Akbar U. Updates in medical and surgical therapies for tourette syndrome. Curr Neurol Neurosci Rep. 2014;14(7):458.
  • Da Cunha C, Boschen SL, Gomez AA, et al. Toward sophisticated basal ganglia neuromodulation: review on basal ganglia deep brain stimulation. Neurosci Biobehav Rev. 2015;58:186–210.
  • Muller-Vahl KR, Grosskreutz J, Prell T, et al. Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms. BMC Neurosci. 2014;15(1):6.
  • Nordstrom EJ, Bittner KC, McGrath MJ, et al. Hyperglutamatergic cortico-striato-thalamo-cortical circuit” breaker drugs alleviate tics in a transgenic circuit model of tourettes syndrome. Brain Res. 2015;1629:38–53.
  • Mian MK, Campos M, Sheth SA, et al. Deep brain stimulation for obsessive-compulsive disorder: past, present, and future. Neurosurg Focus. 2010;29(2):E10.
  • Beszłej J, Siwicki D, Fila-Witecka K, et al. Deep brain stimulation in obsessive-compulsive disorder – case report of two patients. Psychiatr Pol. 2019;53(4):807–824.
  • Gupta A, Khanna S, Jain R. Deep brain stimulation of ventral internal capsule for refractory obsessive-compulsive disorder. Indian J Psychiatry. 2019;61(5):532–536.
  • Menchon JM, Real E, Alonso P, et al. A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. Mol Psychiatry. 2019. DOI:10.1038/s41380-019-0562-6.
  • Park HR, Kim IH, Kang H, et al. Electrophysiological and imaging evidence of sustained inhibition in limbic and frontal networks following deep brain stimulation for treatment refractory obsessive compulsive disorder. PLoS One. 2019;14(7):e0219578.
  • Sun B, Krahl SE, Zhan S, et al. Improved capsulotomy for refractory tourette’s syndrome. Stereotact Funct Neurosurg. 2005;83(2–3):55–56.
  • Schwab RS, Sweet WH, Mark VH, et al. Treatment of intractable temporal lobe epilepsy by stereotactic amygdala lesions. Trans Am Neurol Assoc. 1965;90:12–19.
  • Bourdillon P, Rheims S, Catenoix H, et al. Surgical techniques: stereoelectroencephalography-guided radiofrequency-thermocoagulation (seeg-guided rf-tc). Seizure. 2019. DOI:10.1016/j.seizure.2019.01.021.
  • Leckman JF, Riddle MA, Hardin MT, et al. The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566–573.
  • Cosman ER, Jr., Cosman ER. Sr. Electric and thermal field effects in tissue around radiofrequency electrodes. Pain Med. 2005;6(6):405–424.
  • Johnson KA, Fletcher PT, Servello D, et al. Image-based analysis and long-term clinical outcomes of deep brain stimulation for tourette syndrome: a multisite study. J Neurol Neurosurg Psychiatry. 2019;90(10):1078–1090.
  • Viswanathan A, Jimenez-Shahed J, Baizabal Carvallo JF, et al. Deep brain stimulation for tourette syndrome: target selection. Stereotact Funct Neurosurg. 2012;90(4):213–224.
  • Albin RL, Mink JW. Recent advances in tourette syndrome research. Trends Neurosci. 2006;29(3):175–182.
  • Jimenez-Shahed J. Tourette syndrome. Neurol Clin. 2009;27(3):737–755. vi
  • Grados MA, Walkup JT. A new gene for tourette’s syndrome: a window into causal mechanisms? Trends Genet. 2006;22(6):291–293.
  • Muller-Vahl KR, Meyer GJ, Knapp WH, et al. Serotonin transporter binding in tourette syndrome. Neurosci Lett. 2005;385(2):120–125.
  • Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav. 2008;13(5):383–395.
  • Singer HS. Tourette’s syndrome: from behaviour to biology. Lancet Neurol. 2005;4(3):149–159.
  • Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation–a possible prelude to violence. Science. 2000;289(5479):591–594.
  • Daw ND, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002;15(4–6):603–616.
  • Yan Z. Regulation of gabaergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications. Mol Neurobiol. 2002;26(2–3):203–216.
  • Wong DF, Brasic JR, Singer HS, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in tourette syndrome: clues from an in vivo neurochemistry study with pet. Neuropsychopharmacol. 2008;33(6):1239–1251.